Home > Result Summaries: Compounds > ropinirole > Result Summary for 101468/191

Result Summary for 101468/191

Result Summary

Protocol ID:	101468/191
Clinical Study ID:	SKF-101468/191
Official Title:	A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Ropinirole in Subjects with Restless Legs Syndrome (RLS) Suffering from Periodic Leg Movements of Sleep (PLMS)
Phase:	Phase 3
Study Indications or Diseases:	Restless Legs Syndrome
Generic Name:	ropinirole
Trade/Product Name:	requip;requip
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Allen R, Becker PM, Bogan R, Schmidt M, Kushida CA, Fry JM, Poceta S, Winslow D. Ropinirole Decreases Periodic Leg Movements and Improves Sleep Parameters in Patients with Restless Legs Syndrome. Sleep 2004; 27(5): 907–914